AURKA and colon carcinoma: Furthermore, studies have reported its dysregulation in two colon carcinoma cell lines (SW480 and Caco2) upon knockdown of the aurora kinase A (AURKA) gene [82], in papillary thyroid carcinoma [83], in hepatocellular carcinoma treated with cisplatin [84], and in gastric cancer [85,86].